Nonclassical Congenital Adrenal Hyperplasia and the Polycystic Ovarian Syndrome a

@article{New1993NonclassicalCA,
  title={Nonclassical Congenital Adrenal Hyperplasia and the Polycystic Ovarian Syndrome a},
  author={Maria I. New},
  journal={Annals of the New York Academy of Sciences},
  year={1993},
  volume={687}
}
  • M. New
  • Published 1993
  • Medicine
  • Annals of the New York Academy of Sciences
PCOS has a hormonal pattern that includes an apparent dysfunction in ovarian steroidogenesis, although the sequence (or sequences) of endocrine changes, possibly with inherent paracrine abnormalities that can establish PCOS, are only postulated. Development of PCOS in the setting of androgen overproduction (or persistent disturbances of the hypothalamic-pituitary-adrenal axis even after normalization of androgen levels) points to adrenal enzyme defects, but the precise interaction of gonad and… Expand
Polycystic Ovary Syndrome: A Mysterious Ailment
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women between menarche and menopause. Clinical expression of this syndrome alters but commonly includes menstrualExpand
Congenital Adrenal Hyperplasia: Unresolved Issues.
TLDR
Prenatal treatment with dexamethasone is available to avoid ambiguous genitalia in females affected with classical CAH and the detection of cell-free fetal DNA in maternal plasma has made it possible to make this diagnosis earlier and noninvasively. Expand
Congenital adrenal hyperplasia
TLDR
This Seminar reviews the epidemiology, genetics, pathophysiology, diagnosis, and management of CAH, and provides an overview of clinical challenges and future therapies. Expand
The prevalence of non-classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Greek women with hirsutism and polycystic ovary syndrome.
TLDR
Adrenal NC-CAH due to 21-OHdef as well as adrenal hyperactivity, revealed after ACTH testing, constitutes an important reason of hirsutism and PCOS in these Greek women and both reach a rate of 20%. Expand
Congenital Adrenal Hyperplasia
TLDR
The management of CAH may be complicated by iatrogenic Cushing’s syndrome, inadequately treated hyperandrogenism, or both, andrenatal treatment may decrease virilisation of the affected female foetus, but the efficacy and safety of treating CAH prenatally remains to be fully defined. Expand
A 31-year-old woman with infertility and polycystic ovaries diagnosed with non-classic congenital adrenal hyperplasia due to a novel CYP21 mutation
TLDR
This case confirms the necessity of adding an analysis of 17-OHP when evaluating women with hirsutism and menstrual disturbances and if an elevated value is found, the advantage of performing a mutation analysis to facilitate counseling and decisions on treatment. Expand
Late-onset Congenital Adrenal Hyperplasia or Early-onset Polycystic Ovarian Syndrome: A Clinical Dilemma
TLDR
There is significant overlapping between PCOS and NCCAH, which warrants accurate diagnosis based on hormonal analysis to institute early and appropriate therapy to prevent infertility and androgenic complications later in life. Expand
The prevalence of late onset congenital adrenal hyperplasia in hirsute women from Central Anatolia.
TLDR
The most frequent form of LO CAH seems to be due to 21 OH deficiency among women with PCOS and IH in Central Anatolia, which is likely to be the main reason of hyperandrogenemia in women with hirsutism. Expand
The role of imaging in congenital adrenal hyperplasia.
TLDR
A narrative synthesis of how imaging can help in the management of patients with CAH, especially focused on genitography, ultrasonography, computed tomography, and magnetic resonance imaging is conducted. Expand
Congenital Adrenal Hyperplasia Because of 21-Hydroxylase Deficiency: A Genetic Disorder of Interest to Obstetricians and Gynecologists
TLDR
The reader should be able to recall the epidemiology of carrier status for 21-hydroxylase deficiency, identify phenotypic characteristics for classic and non-classic congenital adrenal hyperplasia, and describe the consequences of 21-Hydroxylases block with respect to production of other hormones and enzymes. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 60 REFERENCES
Adrenal abnormalities in polycystic ovary syndrome.
TLDR
Plasma T, androstenedione, and 11-deoxycortisol responses to metyrapone were excessive in PCOS patients, thus indicating a specific adrenal abnormality. Expand
The polycystic ovary syndrome: pathogenesis and treatment.
TLDR
A theory for the pathogenesis of the polycystic ovary syndrome is proposed that explains the endocrinologic abnormalities of the syndrome and provides a rational approach to therapy and suggests that several causes exist. Expand
Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease.
TLDR
Serum 17-hydroxyprogesterone (17OHP) was measured in normal women and 25 hirsute oligomenorrheic patients, five of whom were shown to have CAH, and human lymphocyte antigen (HLA) typing on family members indicated that the inheritance of the disorder may be linked to B antigens. Expand
Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.
TLDR
It is strongly supported that ovarian 17-KSR defect may cause a syndrome closely resembling PCOD, and genetic control of this enzyme similar in both sexes in men and women in the same family is demonstrated. Expand
Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia.
TLDR
The hormonal and genetic linkage studies indicate that the late-onset (symptomatic) form of 21- hydroxylase deficiency is transmitted by an autosomal recessive gene which is linked to HLA-B. Expand
The incidence of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency among hirsute women.
TLDR
Severe hirsutism, virilization, early onset of symptoms, short stature, familial occurrence, and regular menses were identified as the clinical characteristics associated with late-onset CAH. Expand
Adrenocorticotropic hormone testing in idiopathic hirsutism and polycystic ovarian disease: a test of limited usefulness.
TLDR
Routine adrenocorticotropic hormone testing is not a useful tool in detecting 21-OH deficiency in hyperandrogenic women. Expand
The partial adrenocortical hydroxylase deficiency syndrome in infertile women.
TLDR
It is demonstrated that partial adrenocortical enzyme defects play a significant role in some women with clinical evidence of hyperandrogenism, and, in such women, either glococorticoid therapy alone or in combination with clomiphene is indicated. Expand
Late-onset adrenal hyperplasia in hirsutism.
TLDR
The role of skin sensitivity to androgens is important in determining the clinical expression of this disorder, and a high correlation between late-onset adrenal hyperplasia and HLA antigens B14 and Aw33 is found. Expand
The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia.
TLDR
The most common endocrine disorder in this series of patients with diffuse alopecia was polycystic ovarian disease and hyperandrogenism was noted in 42 of the 109 patients studied. Expand
...
1
2
3
4
5
...